Articles by Disease (Cerebellar Diseases)

High-Throughput Screening of Neuronal Cl- Channels: Why and How?

Journal: Current Neuropharmacology
Volume: 3
Page: 207-216
Author(s): J. W. Lynch

Iptakalim Hydrochloride and Neuronal Protection

Journal: Current Neuropharmacology
Volume: 3
Page: 249-256
Author(s): Jie Wu, Makoto Wakui, Hai Wang and Gang Hu

Selective Neuronal Nitric Oxide Synthase Inhibitors

Journal: Current Topics in Medicinal Chemistry
Volume: 5
Page: 603-624
Author(s): Erik P. Erdal, Elizabeth A. Litzinger, Jiwon Seo, Yaoqiu Zhu, Haitao Ji and Richard B. Silverman

Memory Deficits Correlating with Acetylcholinesterase Splice Shift and Amyloid Burden in Doubly Transgenic Mice

Journal: Current Alzheimer Research
Volume: 2
Page: 291-300
Author(s): Tina M. Rees, Amit Berson, Ella H. Sklan, Linda Younkin, Steven Younkin, Stephen Brimijoin and Hermona Soreq

Possible Use of Autologous Stem Cell Therapies for Alzheimers Disease

Journal: Current Alzheimer Research
Volume: 2
Page: 367-376
Author(s): Kiminobu Sugaya

Depressive Illness and Emotional Learning

Journal: Current Medical Imaging
Volume: 1
Page: 157-176
Author(s): John D. Steele

The Role of AGEs and AGE Inhibitors in Diabetic Cardiovascular Disease

Journal: Current Drug Targets
Volume: 6
Page: 453-474
Author(s): M. C. Thomas, J. W. Baynes, S. R. Thorpe and M. E. Cooper

Molecular Targets of Diabetic Vascular Complications and Potential New Drugs

Journal: Current Drug Targets
Volume: 6
Page: 503-509
Author(s): Roberto Da Ros, Roberta Assaloni and Antonio Ceriello

GABAA Receptor Channel Pharmacology

Journal: Current Pharmaceutical Design
Volume: 11
Page: 1867-1885
Author(s): Graham A.R. Johnston

Molecular Pharmacology of Non-L-type Calcium Channels

Journal: Current Pharmaceutical Design
Volume: 11
Page: 1887-1898
Author(s): Clinton J. Doering and Gerald W. Zamponi